Lung cancer
Lung cancer occurs in the bronchial mucosa or glands, also known as bronchial lung cancer. In the past 50 years, many countries have reported that the incidence of lung cancer has increased significantly. Among male cancer patients, lung cancer has ranked first, and the incidence rate in women has also increased rapidly, accounting for the second or third most common malignant tumors in women. The male-female incidence ratio is 3~5:1, and the age of onset is mostly between 60-79 years old. The cause of lung cancer is still not completely clear. A large amount of data shows that long-term heavy smoking is an important pathogenic factor of lung cancer. For those who smoke more than 40 cigarettes a day for many years, the incidence of squamous cell carcinoma and undifferentiated cancer of the lung is 4 to 10 times higher than that of non-smokers. The incidence of lung cancer in urban residents is higher than that in rural areas, which may be related to air pollution and carcinogens contained in smoke. Therefore, non-smoking should be advocated and urban environmental sanitation work should be strengthened.
Related Drugs
Docetaxel Injection
Indication: 1. It is suitable for the treatment of locally advanced or metastatic breast cancer. 2. It is suitable for the treatment of locally advanced or metastatic non-small cell lung cancer, even after the failure of cisplatin-based chemotherapy.
Manufacturer:
Beijing Eastern Union Biopharmaceuticals, Ltd.
Docetaxel Injection
Indication: 1. Docetaxel is suitable for the treatment of advanced or metastatic breast cancer after failure of previous chemotherapy. Unless it is clinically contraindicated, previous treatment should include anthracycline anticancer drugs. 2. Docetaxel is suitable for the treatment of advanced or metastatic non-small cell lung cancer after failure of chemotherapy based on cisplatin.
Gemcitabine Hydrochloride
Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
Manufacturer:
Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd.
Gemcitabine Hydrochloride
Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
Manufacturer:
Lianyungang JARI Pharmaceutical Co., Ltd.
Yifei Qinghua Paste
Manufacturer:
Darentang Pharmaceutical Factory of Tianjin Pharmaceutical Darentang Group Co., Ltd.
Hexamethylmelamine
Indication: It is mainly used to treat ovarian cancer, and can also be used to treat bronchial lung cancer, breast cancer and malignant lymphoma.
Hexamethylmelamine
Indication: It is mainly used to treat ovarian cancer, and can also be used to treat bronchial lung cancer, breast cancer and malignant lymphoma.
Gemcitabine Hydrochloride for Injection
Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
Manufacturer:
Nanjing Chia Tai-tianqing Pharmaceutical Co., Ltd.
Gemcitabine Hydrochloride for Injection
Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
Manufacturer:
Zhejiang Hisun Pharmaceutical Co., Ltd.